NYQ · Medical - Care Facilities

AGL (AGL) Stock

$99.07 +0.11% NYQ: AGL Healthcare

Valuation

MetricValue
Price$99.07
Market Cap$1.65B
P/E Ratio-3.60
P/B Ratio11.59
P/S Ratio0.25
EPS (TTM)$-24.50
52-Week High$127.15
52-Week Low$7.48
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-318.90%
ROA-31.86%
ROCE-334.13%
Gross Margin-7.10%
Operating Margin-7.10%
Net Margin-6.42%
Debt/Equity0.18
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.5B$2.4B$4.3B$6.1B$5.9B
Operating Profit$-372.0M$-105.0M$-232.0M$-292.0M$-421.0M
Net Profit$-406.0M$-107.0M$-263.0M$-260.0M$-405.0M
EPS$-27.25$-6.50$-16.00$-15.75$-24.50
Op Margin-24.5%-4.4%-5.4%-4.8%-7.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.6B$1.7B$1.7B$1.7B$1.3B
Total Liabilities$495.0M$657.0M$1.1B$1.3B$1.1B
Cash$1.1B$465.0M$114.0M$194.0M$174.0M
Borrowings$60.0M$53.0M$52.0M$44.0M$37.0M

Latest News

Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4% Zacks · Jul 10, 2026 agilon health Reports ACO REACH Model Results for 2024 Performance Year Business Wire · Jul 10, 2026 1 Momentum Stock on Our Buy List and 2 Facing Challenges StockStory · Jul 10, 2026 agilon health Sets Date to Report Second Quarter 2026 Financial Results Business Wire · Jul 7, 2026 What's Making Tenet Healthcare Stock Stand Out Right Now? Zacks · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-148.0M$-131.0M$-156.0M$-58.0M$-106.0M
Investing Cash Flow$-104.0M$-477.0M$-75.0M$127.0M$75.0M
Financing Cash Flow$-15.0M$0$-188.0M$0$-3.0M
Net Cash Flow$916.0M$-547.0M$-393.0M$80.0M$-20.0M
Free Cash Flow$-162.0M$-163.0M$-187.0M$-71.0M$-119.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-5.28%
Quick Ratio1.04
Interest Coverage-60.14
Return 1Y119.96%
Return 3Y-73.85%
Return 5Y-87.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANNX $5.37 +0.75% -3.71 $879.83M 0.00%
DBVTDBV Technologies S.A. $15.84 +0.83% -3.27 $378.92M 0.00%
DH $0.67 -1.38% 4.29 $71.08M 0.00%
EHABEnhabit Inc $13.80 +0.07% -153.33 $706.91M 0.00%
ENGN $1.79 +1.70% -0.70 $91.64M 0.00%

About AGL

AGL is led by CEO Ronald Allan Williams, employs 1,076 people, headquartered in US, publicly traded since 2021.

AGL stock trades at $99.07 with a market capitalization of $1.65B. The stock is valued at a price-to-earnings (P/E) ratio of -3.60, price-to-book of 11.59, price-to-sales of 0.25. Over the past 52 weeks the stock has ranged between $7.48 and $127.15, and currently trades 22.1% below its 52-week high.

On profitability, AGL generates a return on equity (ROE) of -318.90%, return on capital employed of -334.13%, an operating margin of -7.10%, a net profit margin of -6.42%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides